Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Hereditary nonpolyposis colorectal cancer
Other

Hereditary nonpolyposis colorectal cancer

Tracked across 1 events · 6 articles · First seen Jun 08, 2026 · Last active Jun 09, 2026

Sentiment
0
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
6 0
Tech
Oxford, Moderna develop cancer vaccine
The University of Oxford and pharmaceutical firm Moderna>>> have developed a pioneering mRNA vaccine, mRNA-4194, aimed at preventing bowel and ovarian cancers in individuals with Hereditary nonpolyposis colorectal cancer>>>. A clinical trial, named Intercept-Lynch, is…
Impact: Hereditary nonpolyposis colorectal cancer>>> is the genetic condition targeted by the mRNA-4194 vaccine, as individuals with this syndrome are at high risk of various cancers. The vaccine aims to prevent cancer development in these patients.
Jun 08, 2026 · 6 articles
NEWSDESK
Track Hereditary nonpolyposis colorectal cancer live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.